BreedIT Corp. Presenting at Marijuana for Medical Professionals Conference in Denver, Colorado

NEW YORK, September 9, 2014 /PRNewswire/ --

BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated Intelligent Decision Support Software (IDSS) platform for plant breeders and researchers, today announced that Dr. Oded Sagee will give a private lecture on breeding of new strains of medical cannabis at the upcoming Marijuana For Medical Professionals Conference in Denver, Colorado. The presentation will be made on Tuesday, September 9th, 2014 at 5:00 PM (Mountain Time) at the Sherman Street Event Center.

Dr. Sagee is the Founder and Chief Executive Officer of BreedIT Ltd., and a pioneer in the field of agri-high-tech, with in-depth knowledge of agriculture, biotechnology, life sciences, chemistry, and pharmaceuticals. He completed his Ph.D. in Plant Physiology at the Hebrew University of Jerusalem and served as a senior researcher and head of department at the Agricultural Research Organization, Volcani Center, Israel.

Dr. Sagee's lecture, titled Breeding of New Medical Cannabis Varieties, will focus on the increasing role of technology throughout the breeding industry as well as an overview of the Company's activities within the medical cannabis industry. The presentation will also feature a demonstration of iBreedIT® and the measureable impact it provides to breeders.

Breeding is an increasingly complex process and the amount of data generated necessitates a sophisticated technology solution. The cornerstone of iBreedIT® is an infrastructure developed by the world-renown vegetable breeding and research group at the R.H Smith Faculty of Agriculture, Food and Environment of the Hebrew University, to manage their in-house research projects.

The end result is a platform that supports every stage of the breeding process, from planning through the final harvest, and a reduction in the time and expense of bringing products to market.

Dr. Sagee commented on the announcement saying, "iBreedIT is ideally suited for medical cannabis breeders. It not only enables researchers to tag desired genes and nurture specific characteristics, such as CBD and THC levels, its comprehensive documentation capabilities are invaluable for compliance within the highly regulated cannabis and pharmaceutical industries. Finally the cloud-based Software as a Service delivery make it affordable and accessible to ventures of any size."

The conference will convene from September 9-11, 2014 at the Sherman Street Event Center in Denver, Colorado. To register for the conference, or to learn more about the event, visit the conference website http://www.mmjfordoctors.com or contact Martha Montemayor at [email protected].

About the Marijuana for Medical Professionals Conference 

The Marijuana for Medical Professionals Conference (MJMD) is co-sponsored by Healthy Choices Unlimited and the Postgraduate Institute for Medicine. The event was created to provide a professional forum to present and review the full range of options for patients, as well as establish better standards of care for cannabis patients through dialogue between doctors, dispensaries and patients.

Qualified attendees will also be able to earn cannabis-specific Continuing Medical Education (CME) credits during the three-day event. Patients and care-takers are able to attend the conference, however they will not be eligible to receive CME credit.

Each day will be highlight specific topics, featuring lectures by prominent researchers, case study presentations, and interactive learning. Day one will focus on the Endocannabinoid system and implementing treatment plans; day two looks at cannabis use in clinical practice, including oncology and neuromuscular conditions, as well as pediatric epilepsy. The third day will focus on use in mental health and clinical applications such as back pain and geriatrics.

About BreedIT Corp. 

BreedIT Corp (BRDT) http://www.brdt.us, through its Israeli subsidiary, BreedIT Ltd http://www.ibreedit.com , is the developer of highly sophisticated agro-breeding solutions for plant breeders and researchers. BreedIT's proven iBreedIT® - the Intelligent Decision Support System (IDSS) for breeders which was developed by a team consisting of among the world's leading breeding specialists for optimizing the breeding processes, services the plant breeding needs of corporations, research and government institutions. BreedIT's IDSS provides advanced solutions for generating and disseminating knowledge aimed at assisting breeders to plan, manage and analyze their breeding data and to perform research activities quickly and effectively. Founded in 2013, BreedIT Corp has offices in New York, New York and in Rehovot, Israel.  BreedIt Corp's public filings may be viewed at http://www.sec.gov/.

Forward-Looking Statements: 

This press release may contain forward-looking statements, including information about management's view of the Company's future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the "Act"). In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act, and are subject to the safe harbor created by the Act. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its divisions and concepts to be materially different than those expressed or implied in such statements. These risk factors and others are included from time to time in documents the Company files with the Securities and Exchange Commission, including but not limited to, its Form 10-K, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.

Contact:

Lorin Cohen
+1-720-319-7519

SOURCE BreedIT Corp.